Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Development,identification and Function Assay of Monoclonal Antibody Against Platelet Membrane Glycoprotein Ib

Engineering and Characterization of a Chimeric Anti-platelet Glycoprotein Ibα Monoclonal Antibody and Preparation of Its Fab Fragment

Experimental Study of Interaction Between Activated VWF and Targeted Lipid Microbubbles Conjugated with Recombinant GPIba

Experimental study of interaction between activated VWF and targeted lipid microbubbles conjugated with recombinant GPⅠba

[Expression of Antibody Fab Against Platelet IIb/IIIa in E.coli and Characterization of Its Biological Activity].

[Construction and Expression of Mouse-Human Chimeric Fab Fragment Gene of Monoclonal Antibody SZ-2 Against Platelet].

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

Targeted platelet membrane glycoprotein GPIbalpha monoclonal antibody for inhibiting tumor metastasis and screening method thereof

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Novel Antibodies Against Glycoprotein Ibα Inhibit Pulmonary Metastasis by Affecting Vwf-Gpibα Interaction

Cloning, Expression of the Lectin-Egf Domain of P-Selectin, and Preparation of Its Monoclonal Antibody

Establishment of a Multivariate Analysis Based on Photonic Crystal Hydrogel Bead Arrays and Its Application for Detecting Platelet-specific Antibodies

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Tumor metastasis inhibitor of targeted mouse platelet membrane glycoprotein GPIb alpha and identification method of inhibitor

Structural basis for the specific inhibition of glycoprotein Ibα shedding by an inhibitory antibody

Preparation and Identification of a Monoclonal Antibody Against GDDR Protein

Generation and characterization of a recombinant single chain Fv antibody to von Willebrand factor A1 domain from phage display library.

Generation and Characterization of Monoclonal Antibody Against Human PIK3IP1

Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer

Novel Antibodies Against GPIb Alpha Inhibit Pulmonary Metastasis by Affecting Vwf-Gpib Alpha Interaction

Preparation and Characterization of Mabs Against Different Epitopes of CD226 (PTA1).